Read + Share
Barreras P, Vasileiou ES, Filippatou AG, Fitzgerald KC, et al. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum
Disorder and MOG Antibody Disease. Neurology 2022;99:e2504-e2516.
PMID: 36240094
|
 |
|
Barreras P, Vasileiou ES, Filippatou AG, Fitzgerald KC, et al. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum
Disorder and MOG Antibody Disease. Neurology 2022;99:e2504-e2516.
PMID: 36240094
|
|
|
|